Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209377

Expand all

ZINC SULFATE (ZINC SULFATE)
EQ 10MG BASE/10ML (EQ 1MG BASE/ML)
Marketing Status: Prescription
Active Ingredient: ZINC SULFATE
Proprietary Name: ZINC SULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 10MG BASE/10ML (EQ 1MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N209377
Product Number: 003
Approval Date: Apr 15, 2020
Applicant Holder Full Name: AMERICAN REGENT INC
Marketing Status:  Prescription
Patent and Exclusivity Information
ZINC SULFATE (ZINC SULFATE)
EQ 25MG BASE/5ML (EQ 5MG BASE/ML)
Marketing Status: Prescription
Active Ingredient: ZINC SULFATE
Proprietary Name: ZINC SULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 25MG BASE/5ML (EQ 5MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209377
Product Number: 002
Approval Date: Jul 18, 2019
Applicant Holder Full Name: AMERICAN REGENT INC
Marketing Status:  Prescription
Patent and Exclusivity Information
ZINC SULFATE (ZINC SULFATE)
EQ 30MG BASE/10ML (EQ 3MG BASE/ML)
Marketing Status: Prescription
Active Ingredient: ZINC SULFATE
Proprietary Name: ZINC SULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 30MG BASE/10ML (EQ 3MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209377
Product Number: 001
Approval Date: Jul 18, 2019
Applicant Holder Full Name: AMERICAN REGENT INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English